» Articles » PMID: 36986546

Application of Convergent Science and Technology Toward Ocular Disease Treatment

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Mar 29
PMID 36986546
Authors
Affiliations
Soon will be listed here.
Abstract

Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives.

Citing Articles

Expanding Ocular Care in the Emergency Department: A Comprehensive Review of the Utility of Point-of-Care Ultrasound for Ocular Emergencies.

Alsulami R, Almutairi J, Almatrafi M, Othman B Cureus. 2024; 16(11):e74548.

PMID: 39735154 PMC: 11676468. DOI: 10.7759/cureus.74548.


Progranulin Facilitates Corneal Repair Through Dual Mechanisms of Inflammation Suppression and Regeneration Promotion.

Yan D, Zhang Y, Huang Y, Ouyang W Inflammation. 2024; 47(5):1648-1666.

PMID: 38460093 DOI: 10.1007/s10753-024-01999-3.

References
1.
Elmotasem H, Awad G . A stepwise optimization strategy to formulate gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery. Asian J Pharm Sci. 2020; 15(5):617-636. PMC: 7610214. DOI: 10.1016/j.ajps.2019.09.003. View

2.
Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N . Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomedicine. 2013; 8:495-503. PMC: 3576887. DOI: 10.2147/IJN.S30725. View

3.
Yadav K, Sharma S, Londhe V . Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma. Life Sci. 2020; 243:117303. DOI: 10.1016/j.lfs.2020.117303. View

4.
Gautam N, Kesavan K . Development of microemulsions for ocular delivery. Ther Deliv. 2017; 8(5):313-330. DOI: 10.4155/tde-2016-0076. View

5.
Coursey T, Henriksson J, Marcano D, Shin C, Isenhart L, Ahmed F . Dexamethasone nanowafer as an effective therapy for dry eye disease. J Control Release. 2015; 213:168-174. DOI: 10.1016/j.jconrel.2015.07.007. View